ABEO vs CUBE · rev $3.5M vs P/E 25, rev $1.07B
Abeona Therapeutics Inc (ABEO) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported ABEO revenue for 2023-12-31 was $3.5M. Net income was -$54.2M. Revenue was up 147.5% from 2022-12-31 to 2023-12-31. ABEO currently screens at market cap $301.8M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
ABEO currently screens at market cap $301.8M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the ABEO and CUBE stock pages for the full models.
Not investment advice.